Determinants of cognition in autoimmune limbic encephalitis-A retrospective cohort study

被引:13
|
作者
Mueller, Christoph [1 ]
Langenbruch, Lisa M. [1 ]
Rau, Johanna M. H. [1 ]
Brix, Tobias [2 ]
Strippel, Christine [1 ]
Dik, Andre [1 ]
Golombeck, Kristin S. [1 ]
Moenig, Constanze [1 ]
Raeuber, Saskia J. [1 ,3 ]
Kovac, Stjepana [1 ]
Wiendl, Heinz [1 ]
Meuth, Sven G. [1 ,3 ]
Boelte, Jens [4 ]
Johnen, Andreas [1 ]
Melzer, Nico [1 ,3 ]
机构
[1] Westfalische Wilhelms Univ Munster, Inst Translat Neurol, Dept Neurol, Munster, Germany
[2] Westfalische Wilhelms Univ Munster, Inst Med Informat, Munster, Germany
[3] Heinrich Heine Univ Dusseldorf, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany
[4] Westfalische Wilhelms Univ Munster, Inst Psychol, Munster, Germany
关键词
autoantibody; autoimmune limbic encephalitis; cognition; determinant; inflammation; memory; neuropsychology; TEMPORAL-LOBE EPILEPSY; GLUTAMIC-ACID DECARBOXYLASE; GATED POTASSIUM CHANNEL; COMPLEX; ONSET; LGI1; ANTIBODIES; IMPAIRMENT; PATTERNS; AMYGDALA;
D O I
10.1002/hipo.23375
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Autoimmune limbic encephalitis (ALE) is the most common type of autoimmune encephalitis (AIE). Subacute memory disturbance, temporal lobe seizures, and psychiatric symptoms are clinical hallmarks of the disease. However, little is known on the factors contributing to cognitive functioning in ALE. Hence, we here investigate major determinants of cognitive functioning in ALE. In a retrospective analysis of 102 patients with ALE, we first compared verbal learning capacity, nonverbal learning capacity, and attentional and executive functioning by absence or presence of different types of neural autoantibodies (AABs). Subsequently we established three linear regression models including 63, 38, and 61 patients, respectively to investigate how cognitive functioning in these domains may depend on common markers of ALE such as intrathecal inflammation, blood-cerebrospinal fluid (CSF)-barrier function, mesiotemporal epileptiform discharges and slowing, determined by electroencephalography (EEG) and structural mesiotemporal changes, measured with magnetic resonance imaging (MRI). We also accounted for possible effects of cancer- and immunotherapy and other centrally effective medication. There was no effect of AAB status on cognitive functioning. Although the regression models could not predict verbal and nonverbal learning capacity, structural mesiotemporal neural network alterations on T2-/fluid attenuated inversion recovery (FLAIR)-signal-weighted MRI and mesiotemporal epileptiform discharges or slowing on EEG exerted a significant impact on memory functions. In contrast, the regression model significantly predicted attentional and executive functioning with CSF white blood cell count and centrally effective medication being significant determinants. In this cohort, cognitive functioning in ALE does not depend on the AAB status. Common markers of ALE cannot predict memory functioning that only partially depends on structural and functional alterations of mesiotemporal neural networks. Common markers of ALE significantly predict attentional and executive functioning that is significantly related to centrally effective medication and CSF white blood cell count, which may point toward inflammation affecting brain regions beyond the limbic system.
引用
收藏
页码:1092 / 1103
页数:12
相关论文
共 50 条
  • [1] Clinical scales in autoimmune encephalitis-A retrospective monocentric cohort study
    Macher, Stefan
    Bsteh, Gabriel
    Hoftberger, Romana
    Berger, Thomas
    Rommer, Paulus
    Zrzavy, Tobias
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2023, 10 (10): : 1768 - 1775
  • [2] Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study
    Zrzavy, Tobias
    Hoftberger, Romana
    Wimmer, Isabella
    Berger, Thomas
    Rommer, Paulus
    Macher, Stefan
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] VGKC LIMBIC ENCEPHALITIS-A CASE SERIES
    Knight, Matthew
    Choung, Mi Sun
    Willis, Mark
    Hamandi, Khalid
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [4] Autoimmune Encephalitis-A Multifaceted Pathology
    Neatu, Monica
    Jugurt, Ana
    Covaliu, Anca
    Davidescu, Eugenia Irene
    Popescu, Bogdan Ovidiu
    [J]. BIOMEDICINES, 2023, 11 (08)
  • [5] Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
    Lee, Woo-Jin
    Lee, Soon-Tae
    Byun, Jung-Ick
    Sunwoo, Jun-Sang
    Kim, Tae-Joon
    Lim, Jung-Ah
    Moon, Jangsup
    Lee, Han Sang
    Shin, Yong-Won
    Lee, Keon-Joo
    Kim, Soyun
    Jung, Keun-Hwa
    Jung, Ki-Young
    Chu, Kon
    Lee, Sang Kun
    [J]. NEUROLOGY, 2016, 86 (18) : 1683 - 1691
  • [6] Autoimmune Encephalitis-A Diagnostic Challenge for the Neurologist
    Khanna, Laxmi
    Gourie-Devi, Mandaville
    Verma, Ritu
    [J]. NEUROLOGY, 2022, 99 (23) : S76 - S76
  • [7] Autoimmune limbic encephalitis
    Wingfield, T.
    McHugh, C.
    Vas, A.
    Richardson, A.
    Wilkins, E.
    Bonington, A.
    Varma, A.
    [J]. CLINICAL MEDICINE, 2012, 12 (01): : 96 - 96
  • [8] Autoimmune limbic encephalitis
    Derry, Christopher P.
    Wilkie, Mark D.
    Salmon, Rustam Al-Shahi
    Davenport, Richard J.
    [J]. CLINICAL MEDICINE, 2011, 11 (05) : 476 - 478
  • [9] Autoimmune limbic encephalitis
    Vedeler, C. A.
    Storstein, A.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 : 63 - 67
  • [10] Autoimmune limbic encephalitis
    Didelot, Adrien
    Honnorat, Jerome
    [J]. FUTURE NEUROLOGY, 2011, 6 (01) : 97 - 111